KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : 방영학

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 11건 중 1-11 번을 표시중입니다.

1 Article Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma 강지훈 ; 김도훈 ; 김성배 ; et al 2021
2 Article Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines 김규표 ; 김선영 ; 김정은 ; et al 2021
3 Article Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice 김선영 ; 김정은 ; 김지원 ; et al 2021
4 Article Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 김형돈 ; 류백렬 ; 방영학 ; et al 2021
5 Article Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis 김형돈 ; 방영학 ; 유창훈 ; et al 2021
6 Article Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis 김강모 ; 류백렬 ; 박능화 ; et al 2020
7 Article Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study 강명주 ; 강버들 ; 강정헌 ; et al 2020
8 Article Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events 강명주 ; 김일환 ; 류백렬 ; et al 2020
9 Article Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis 김형돈 ; 류백렬 ; 방영학 ; et al 2021
10 Article Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib 김형돈 ; 류백렬 ; 방영학 ; et al 2021
11 Article Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis 김형돈 ; 류백렬 ; 박숙련 ; et al 2021

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.